Analyzing Effects of Provider Education and Management Approach to Pediatric Obesity

Regina Judge1, Jaquetta Randall2, Allison Hayhurst2

  • 1Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710. rnmoorepnp@gmail.com.

Insights

African-Americans with hypertension need better self-management tools. This pilot study integrates technology-based interventions into community programs to improve blood pressure control.

Area of Science:

  • Public Health
  • Health Informatics
  • Chronic Disease Management

Background:

  • African-Americans exhibit suboptimal blood pressure control and lower hypertension self-management rates.
  • Community support is vital for chronic illness management but often lacks technological integration.
  • Existing interventions do not fully leverage technology-based interventions (TBI).

Purpose of the Study:

  • To describe the design and rationale of a pilot study.
  • To integrate TBI into a community-based participatory approach for hypertension self-management.
  • To address the gap in technology-enhanced community support for African-Americans with hypertension.

Main Methods:

  • Pilot study design utilizing a community-based participatory approach.
  • Incorporation of technology-based interventions (TBI) into the study protocol.
  • Focus on enhancing hypertension self-management among African-Americans.

Main Results:

  • Pilot study is ongoing; results not yet available.
  • The study design aims to assess the feasibility and effectiveness of integrated TBI.
  • Rationale focuses on leveraging community strengths with technological innovation.

Conclusions:

  • The study proposes an innovative model combining community support with TBI.
  • This approach seeks to improve hypertension self-management in a vulnerable population.
  • Further research is needed to evaluate the impact of this integrated intervention.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
138
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
135
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
766
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
763
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K